Business
Termination of Proposed Acquisition of Mayne Pharma
BRIDGEWATER, N.J., December 11, 2025--Cosette Pharmaceuticals, Inc. (Cosette), a U.S.-based, fully integrated pharmaceutical company, confirms that on 9 December 2025 it served a notice on Mayne Pharma Group Limited (Mayne Pharma, ASX: Ticker MYX) terminating the agreement between Cosette and Mayne Pharma under which Cosette was to acquire all the outstanding shares of Mayne Pharma (Scheme Implementation Deed). Cosette also notes the announcements from Mayne Pharma on 10 December 2025 and 11 Dec
About this update from Mayne Pharma Group Ltd.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":309,"url":"https://media.zenfs.com/en/business-wire.com/4e052e13a75144f21c2e22d6e026bcad"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/1JGIPXBTG6Zev6HJGHt.bg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTYxODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/4e052e13a75144f21c2e22d6e026bcad","width":480,"height":309},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/iyoMuylAx8MZ.6z9bDgyuA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTQxMjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/4e052e13a75144f21c2e22d6e026bcad","width":480,"height":309}},"lazy":false},{"type":"text","content":"BRIDGEWATER, N.J., December 11, 2025--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc. (Cosette), a U.S.-based, fully integrated pharmaceutical company, confirms that on 9 December 2025 it served a notice on Mayne Pharma Group Limited (Mayne Pharma, ASX: Ticker MYX) terminating the agreement between Cosette and Mayne Pharma under which Cosette was to acquire all the outstanding shares of Mayne Pharma (Scheme Implementation Deed). Cosette also notes the announcements from Mayne Pharma on 10 December 2025 and 11 December 2025 and confirms that on 11 December 2025 Mayne Pharma served its own notice of termination of the Scheme Implementation Deed on Cosette.","length":661,"tagName":"p"},{"type":"text","content":"Both parties’ notices of termination follow a ruling from the Treasurer of Australia blocking the proposed transaction and the expiry of the end date under the Scheme Implementation Deed in November.","length":199,"tagName":"p"},{"type":"text","content":"Cosette strongly rejects Mayne Pharma’s claims that it has breached the Scheme Implementation Deed and believes Mayne Pharma’s 10 December and 11 December ASX announcements contain material inaccuracies. Cosette has at all times been fully transparent in its engagement with Australian regulators and complied with its legal obligations in all respects, including in respect of the Scheme Implementation Deed. Cosette will vigorously defend itself against Mayne’s allegations if required. In addition, Cosette intends to pursue its appeal of the adverse judgment of the Supreme Court of New South Wales, and if necessary, pursue claims against Mayne Pharma fo...